Clinical Trial Update: Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma

View source ↗

Summary

A recruiting clinical trial investigating lipid metabolites as potential biomarkers for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hepatocellular Carcinoma | Status: RECRUITING